Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

New Delhi: Zydus Lifesciences Ltd on Friday announced a partnership with Apollo Hospitals to offer Shield multi-cancer detection test to patients in India.

Through its exclusive agreement with Guardant Health, Inc, a leading precision oncology company, Zydus Lifesciences has the rights to make the Shield multi-cancer detection (MCD) test available in India.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.